Allogeneic Anti-CD19 CAR-T for Refractory Graves' Disease
NCT07129642
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
5
Enrollment
OTHER
Sponsor class
Conditions
Graves Disease
Interventions
BIOLOGICAL:
Allogeneic CAR-T
Sponsor
Shanghai Zhongshan Hospital